#USA #Chicago #Brainomix #AI Imaging #3DR Labs

Brainomix and 3DR Labs Join Forces for Stroke Care Innovation

In a landmark collaboration, Brainomix, known for its pioneering work in artificial intelligence (AI) imaging solutions for strokes, has partnered with 3DR Labs, a leader in medical imaging services. Announced on June 24, 2025, this partnership aims to enhance the quality of stroke care across the United States through the integration of the clinically validated and FDA-cleared Brainomix 360 Stroke platform.

What is Brainomix 360 Stroke?

Brainomix 360 Stroke is not just any imaging tool; it is a cutting-edge platform powered by advanced AI algorithms designed to provide detailed insights that aid in making informed treatment decisions for stroke patients. This tool stands out because it has been shown to significantly enhance stroke treatment rates. According to the largest real-world evaluation of stroke AI, facilities adopting Brainomix experienced over a 50% increase in the rates of mechanical thrombectomy, a critical intervention in acute stroke care.

The Expertise of 3DR Labs

3DR Labs brings its own expertise to the table, specializing in 3D imaging and advanced post-processing services that are vital for medical imaging. With a robust team of over 250 certified radiologic technologists, 3DR Labs ensures that complex image reconstructions are performed swiftly and accurately, which supports clinicians in providing high-quality patient care. The partnership also coincides with 3DR Labs’ recent establishment of its Neurology Center of Excellence. This dedicated facility enhances post-processing services specifically for stroke patients and those requiring pre-surgical planning for brain and spine conditions.

Streamlined Clinical Workflows

The collaboration between Brainomix and 3DR Labs goes beyond just imaging solutions. With 3DR's AI Labs, a comprehensive clinical workflow solution, clinicians will gain streamlined access to crucial imaging insights. This integration will not only enhance the quality and speed of stroke care but will also foster efficiency in medical imaging workflows, thereby directly benefitting patient management.

Leadership Perspectives

Dr. Michalis Papadakis, CEO and Co-Founder of Brainomix, expressed his enthusiasm for the partnership, noting that “Our teams now have an opportunity to deliver a comprehensive and seamless solution that can help stroke teams optimize the care they provide to patients.” This sentiment was echoed by Dr. Rob Falk, Chief Medical Officer of 3DR Labs, who highlighted that the partnership would enhance the rapid and accurate assessment of patient eligibility for time-sensitive interventions based on stroke severity.

CEO of 3DR Labs, Mike Jackman, also acknowledged the impact of this partnership, stating, “By integrating Brainomix into 3DR’s AI Labs, we expand access to validated, high-impact stroke decision-support tools.” The focus remains clear: to not only reduce time-to-treatment for patients but also significantly improve clinical outcomes.

The Path Ahead

As Brainomix and 3DR Labs move forward, their synergistic efforts are expected to streamline the path to recovery for stroke patients while setting a new standard in the realm of acute stroke management. With a shared commitment to precision and patient care, this partnership is poised to make significant strides in addressing one of the most urgent healthcare challenges today.

In summary, the union of Brainomix and 3DR Labs represents a significant advancement in stroke care technology, demonstrating the powerful potential of AI to transform healthcare practices. This initiative not only enhances treatment capabilities but also seeks to improve the overall experience for both clinicians and patients alike.